We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Inflammatory Markers in Preeclampsia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01385813
Recruitment Status : Completed
First Posted : June 30, 2011
Last Update Posted : July 18, 2011
Information provided by:
Oslo University Hospital

Brief Summary:
This is an investigation of inflammatory markers in women destined to develop preeclampsia.

Condition or disease

Study Type : Observational
Actual Enrollment : 129 participants
Observational Model: Case Control
Time Perspective: Retrospective
Study Start Date : January 1999
Primary Completion Date : May 2004
Study Completion Date : May 2004

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Pregnant women who develop preeclampsia
pregnant women who develop preeclampsia (n =43) compared to pregnant women fulfilling a normotensive pregnancy (n= 86).

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 43 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The study comprised 43 pregnant women who developed preeclampsia and 86 pregnant women who fulfilled a normotensive pregnancy.

All women were of Caucasian origin, and were nulliparous.


Inclusion Criteria:

  • Caucasian origin

Exclusion Criteria:

  • Previous diseases e.g. cardiovascular disease, diabetes, hypertension, inflammatory bowel disease, serious organ disease

Responsible Party: Professor Lars Mørkrid, University of Oslo
ClinicalTrials.gov Identifier: NCT01385813     History of Changes
Other Study ID Numbers: INFLAMMARPE11
First Posted: June 30, 2011    Key Record Dates
Last Update Posted: July 18, 2011
Last Verified: May 2011

Keywords provided by Oslo University Hospital:
inflammatory markers
serological biobank
To assess whether the inflammatory markers could be useful
in order to identify pregnant women at risk to
develop preeclampsia

Additional relevant MeSH terms:
Hypertension, Pregnancy-Induced
Pregnancy Complications